6.25 USD
↗ 0.15 (2.38%)LIVE (AS OF 03:23 PM EDT)
GT Biopharma Inc. Common Stock
GTBPNASDAQ • USD
Market: OPEN
GTBP is currently priced at $6.25. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. GTBP is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 2, 2026.
Open?$6.13
High?$6.90
Low?$5.84
Prev. Close?$6.10
Volume?31.4K
Avg. Volume?264.9K
VWAP?$6.45
Rel. Volume?0.12x
Bid / Ask
Bid?$5.32 × 100
Ask?$7.28 × 100
Spread?$1.96
Midpoint?$6.30
Valuation & Ratios
Market Cap?11.0M
Shares Out?1.8M
Float?1.2M
Float %?64.2%
P/E Ratio?N/A
P/B Ratio?3.08
EPS?-$18.16
Dividend?2.08%
Ex-Dividend?N/A
News
Profile
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
Themes
Employees
1
Market Cap
11.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-02-11
Address
505 MONTGOMERY STREET
SAN FRANCISCO, CA 94111
Phone: (800) 304-9888
SAN FRANCISCO, CA 94111
Phone: (800) 304-9888
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?-182.52Distress
Confidence?53%Low
Short InterestSqueeze Risk
Short % of Float?22.17%Squeeze Risk
Short Interest?256.6K
Days to Cover?1.4
Free Float1.2M
Avg Daily Volume187.3K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.61Strong
Quick Ratio?2.61Strong
Cash Ratio?2.24Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.08FAIR▾
Peers100
S&P55
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-917.9%WEAK▾
S&P3
ROA?-566.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-14426000
Enterprise Value?$6.0M
Fundamentals ratios updated end of day